VTAK is having an abnormal dayBoth the price and the volume is abnormal today. If it closes strong today, the potential to go up is high. Again it is just a speculation, and the only way to find out is to bet on it. Stop loss 1.45 area, target 4.30
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−12.9562 USD
−70.57 M USD
442.00 K USD
2.41 M
About Catheter Precision, Inc.
Sector
Industry
CEO
David A. Jenkins
Website
Headquarters
Fort Mill
Founded
2002
FIGI
BBG0029BD0V2
Catheter Precision, Inc. engages in the design, manufacture and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for accurate positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins in September 2002 and is headquartered in Fort Mill, SC.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VTAK is 0.4774 USD — it has decreased by −2.57% in the past 24 hours. Watch Catheter Precision, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Catheter Precision, Inc. stocks are traded under the ticker VTAK.
VTAK stock has fallen by −2.57% compared to the previous week, the month change is a 50.41% rise, over the last year Catheter Precision, Inc. has showed a −89.53% decrease.
VTAK reached its all-time high on Sep 27, 2018 with the price of 275,000.0000 USD, and its all-time low was 0.3112 USD and was reached on Oct 9, 2024. View more price dynamics on VTAK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VTAK stock is 8.17% volatile and has beta coefficient of 4.49. Track Catheter Precision, Inc. stock price on the chart and check out the list of the most volatile stocks — is Catheter Precision, Inc. there?
Today Catheter Precision, Inc. has the market capitalization of 1.34 M, it has decreased by −41.75% over the last week.
Yes, you can track Catheter Precision, Inc. financials in yearly and quarterly reports right on TradingView.
Catheter Precision, Inc. is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
VTAK earnings for the last quarter are −5.57 USD per share, whereas the estimation was −2.60 USD resulting in a −114.23% surprise. The estimated earnings for the next quarter are −1.80 USD per share. See more details about Catheter Precision, Inc. earnings.
Catheter Precision, Inc. revenue for the last quarter amounts to 93.00 K USD, despite the estimated figure of 300.00 K USD. In the next quarter, revenue is expected to reach 1.10 M USD.
VTAK net income for the last quarter is −4.22 M USD, while the quarter before that showed −2.67 M USD of net income which accounts for −57.76% change. Track more Catheter Precision, Inc. financial stats to get the full picture.
No, VTAK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 14.00 employees. See our rating of the largest employees — is Catheter Precision, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Catheter Precision, Inc. EBITDA is −8.60 M USD, and current EBITDA margin is −3.42 K%. See more stats in Catheter Precision, Inc. financial statements.
Like other stocks, VTAK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Catheter Precision, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Catheter Precision, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Catheter Precision, Inc. stock shows the sell signal. See more of Catheter Precision, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.